echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > JCEM: Analysis of the efficacy of somarutide on cystic fibrosis-related diabetes

    JCEM: Analysis of the efficacy of somarutide on cystic fibrosis-related diabetes

    • Last Update: 2020-06-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Although there is evidence that poor blood sugar control is associated with poor clinical outcomes in patients, most cystic fibrosis-related diabetes (CFRD) patients have poor blood sugar controlRecently, the authoritative journal Journal of Endocrinology and Metabolic Diseases published a study aimed at clarifying the efficacy of increasing sonmalutide (GLP-1RA) in basic insulin therapy for blood sugar controlsubjects in the study used somarutide weekly instead of fast-acting insulin and continued to use basic insulinThe researchers measured the levels of glycifyding hemoglobin in CFRD patients and monitored their blood sugar continuouslythe 3 months after the addition of sommarnotide treatment, the subjects' blood sugar control improved significantly, with glycifyding hemoglobin decreased from 9.1% to 6.7%, and continuous blood sugar monitoring was a stable sugar reduction pattern (average blood sugar was 142 mg/dL, SD was 51)There was no significant increase in plasma trypsin concentration, it is possible to see that small doses of somarutide can replace insulin in meals, and that combined with basic insulin can control blood sugar in CFRD patients at optimal levels
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.